Ghosh AK, Kovela S, Sharma A, Shahabi D, Ghosh AK, Hopkins DR, Yadav M, Johnson ME, Agniswamy J, Wang YF, Hattori SI, Higashi-Kuwata N, Aoki M, Amano M, Weber IT, Mitsuya H.

Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands.

ChemMedChem doi: 10.1002/cmdc.202200058,2022.  doi: 10.1002/cmdc.202200058.

https://pubmed.ncbi.nlm.nih.gov/35170223/

Kawano Y, Sasano T, Arima Y, Kushima S, Tsujita K, Matsuoka M, Hata H.

A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.

Biochem Biophys Res Commun 587: 153-159,2022. doi: 10.1016/j.bbrc.2021.11.102.

https://pubmed.ncbi.nlm.nih.gov/34875534/

Kawano Y, Hata H, Takashio S, Tsujita K, Ueda M, Matsuoka M.

Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma

Br J Haematol ,2022. doi: 10.1111/bjh.18234. Online ahead of print.

https://pubmed.ncbi.nlm.nih.gov/35524546/

Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, Hironori Hayashi, Kazuya Hasegawa, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya.

Fluorine-Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier (BBB) Penetration Property of Novel Central Nervous System (CNS)-targeting HIV-1 Protease Inhibitors In Vitro.

Antimicrob Agents Chemother. 2022 Jan 3; AAC0171521. doi: 10.1128/AAC.01715-21.

https://journals.asm.org/doi/10.1128/AAC.01715-21

https://pubmed.ncbi.nlm.nih.gov/34978889/

Tamanoi D, Saruwatari K, Imamura K, Sato R, Jodai T, Hamada S, Tomita Y, Saeki S, Ueno S, Yonemura Y, Ichiyasu H, Sakagami T.

case of pembrolizumab-related immune thrombocytopenia in a patient with lung adenocarcinoma treated by radiotherapy: potential immune-related adverse event elicited by radiation therapy.

Internal Med 61(11):1731-1734,2022. doi: 10.2169/internalmedicine.

https://pubmed.ncbi.nlm.nih.gov/34776479/

Higuchi Y, Yasunaga JI, Matsuoka M.

HTLV-1’s foxy strategy for survival and Transmission.

Front Virol doi: 10.3389/fviro.2021.792659,2022.

https://www.frontiersin.org/articles/10.3389/fviro.2021.792659/full

Mitsuhiro Uchiba, Masao Matsuoka.

Using weighted harmonic mean for prediction of APTT in the mixing test.

Thrombosis Update.

Volume 8, August 2022, 100114.

https://www.sciencedirect.com/science/article/pii/S2666572722000189?via%3Dihub

Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi Y, Hidaka M, Sasaki H, Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura K, Tatetsu H, Kato T, Kawakita T, Suehiro Y, Ishitsuka K, Iida S, Matsutani T, Utsunomiya A, Ueda R, Ishida T.

Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukemia-lymphoma patients receiving mogamulizumab.

Br J Haematol 196(3):629-638,2022. doi: 10.1111/bjh.17895. Epub 2021 Oct 10.

https://pubmed.ncbi.nlm.nih.gov/34632569/

Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, Imaizumi Y, Watanabe M, Saito Y, Ito Y, McClure MB, Tabata M, Shingaki S, Yoshifuji K, Chiba K, Okada A, Kakiuchi N, Nannya Y, Kamiunten A, Tahira Y, Akizuki K, Sekine M, Shide K, Hidaka T, Kubuki Y, Kitanaka A, Hidaka M, Nakano N, Utsunomiya A, Sica RA, Acuna-Villaorduna A, Janakiram M, Shah UA, Ramos JC, Shibata T, Takeuchi K, Takaori-Kondo A, Miyazaki Y, Matsuoka M, Ishitsuka K, Shiraishi Y, Miyano S, Ogawa S, Ye BH, Shimoda K, Kataoka K.

Whole-genome landscape of adult T-cell leukemia/lymphoma.

Blood 139(7):967-982,2022. doi: 10.1182/blood.2021013568.

https://pubmed.ncbi.nlm.nih.gov/34695199/

Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022. doi: 10.1016/j.jtct.2021.10.021

https://pubmed.ncbi.nlm.nih.gov/34774818/

Fuchida S, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022.  doi: 10.1016/j.jtct.2021.10.021.

https://pubmed.ncbi.nlm.nih.gov/34774818/

Shichijo T, Tatetsu H, Nosaka K, Higuchi Y, Kikukawa Y, Inoue Y, Toyoda K, Yasunaga JI, Matsuoka M.

Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.

eJHaem 1–9,2022.

https://onlinelibrary.wiley.com/doi/10.1002/jha2.393

Zhao T, Wang Z, Fang J, Chengc W, Zhang Y, Huang J, Xu L, Zeng L, Jin Z, and Matsuoka M.

HTLV-1 activates YAP by NF-κB/p65 to promote oncogenesis.

Proc Natl Acad Sci USA  119(9):e2115316119,2022. doi: 10.1073/pnas.2115316119.

https://pubmed.ncbi.nlm.nih.gov/35210364/

Nosaka K, Crawford B, Yi J, Kuan W, Matsumoto T, Takahashi T.

Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.

Eur J Haematol 108(3):212-222,2022.  doi: 10.1111/ejh.13728.

https://pubmed.ncbi.nlm.nih.gov/34862665/

Onishi C, Nishikori M, Yakushijin K, Kurahashi S, Nakazawa H, Takamatsu Y, Hashimoto Y, Tatetsu H, Nawa Y, Yoshida M, Kobayashi T, Oyake T, Yano S, Oride A, Suzuki R.

Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study.

Int J Hematol 115(3):382-390,2022. doi: 10.1007/s12185-021-03281-w.

https://pubmed.ncbi.nlm.nih.gov/34981434/

Inoue Y, Nishimura N, Murai M, Matsumoto M, Watanabe M, Yamada A, Izaki M, Nosaka K, Matsuoka M.

Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.

Int J Hematol 115(3):435-9,2022.  doi: 10.1007/s12185-021-03250-3.

https://pubmed.ncbi.nlm.nih.gov/34705226/

Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.

Two-year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia.

Cancer Sci online ahead of print (DOI:10.1111/cas.15344)

https://pubmed.ncbi.nlm.nih.gov/35332633/

Ikezoe T, Noji H, Ueda Y, Kanda Y, Okamoto S, Usuki K, Matsuda T, Akiyama H, Shimono A, Yonemura Y, Kawaguch T, Chiba S, Kanakura Y, Nishimura J, Ninomiya H, Obara N.

Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab:post-marketing surveillance in Japan.

Int J Hematol 115(4):470-480,2022. doi: 10.1007/s12185-022-03287-y.

https://pubmed.ncbi.nlm.nih.gov/35146630/

Rajib S.A, Ogi Y, Hossain M.B, Ikeda T, Tanaka E, Kawaguchi T, Satou Y.

A SARS-CoV-2 Delta variant containing mutation in the probe binding regions used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result.

J Infect Chemother 28(5):669-677,2022. doi: 10.1016/j.jiac.2022.01.019

https://pubmed.ncbi.nlm.nih.gov/35144878/